Judith Sebolt

405 total citations
9 papers, 319 citations indexed

About

Judith Sebolt is a scholar working on Molecular Biology, Cancer Research and Clinical Biochemistry. According to data from OpenAlex, Judith Sebolt has authored 9 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Clinical Biochemistry. Recurrent topics in Judith Sebolt's work include Biochemical and Molecular Research (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Metabolism and Genetic Disorders (4 papers). Judith Sebolt is often cited by papers focused on Biochemical and Molecular Research (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Metabolism and Genetic Disorders (4 papers). Judith Sebolt collaborates with scholars based in United States and Japan. Judith Sebolt's co-authors include George Weber, Takashi Aoki, Robert Jackson, May S. Lui, J. E. Denton, Wilbur R. Leopold, John N. Eble, John L. Glover, Daniel D. Von Hoff and Joan L. Shillis and has published in prestigious journals such as Biochemical Pharmacology, Life Sciences and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Judith Sebolt

9 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judith Sebolt United States	9	258	76	60	54	49	9	319
June P. Davis United States	7	345 1.3×	50 0.7×	23 0.4×	69 1.3×	26 0.5×	8	494
Glenys M. Otter United States	11	211 0.8×	99 1.3×	21 0.3×	40 0.7×	111 2.3×	24	369
Ming-Yu Chu United States	5	248 1.0×	89 1.2×	49 0.8×	49 0.9×	61 1.2×	7	352
Judith A. Besserer United States	8	241 0.9×	122 1.6×	15 0.3×	41 0.8×	95 1.9×	10	397
Richard W. Dyke United States	10	192 0.7×	157 2.1×	21 0.3×	54 1.0×	48 1.0×	13	415
C. P. Rhoads United States	10	140 0.5×	74 1.0×	24 0.4×	24 0.4×	30 0.6×	20	453
George S. Tarnowski United States	12	144 0.6×	55 0.7×	40 0.7×	11 0.2×	44 0.9×	27	334
Kazuhisa Taketa Japan	9	187 0.7×	54 0.7×	52 0.9×	10 0.2×	23 0.5×	22	437
Claudia P. Schroeder United States	12	142 0.6×	57 0.8×	55 0.9×	55 1.0×	22 0.4×	39	360
Henricus J. Broxterman Netherlands	13	358 1.4×	531 7.0×	44 0.7×	70 1.3×	13 0.3×	18	625

Countries citing papers authored by Judith Sebolt

Since Specialization

Citations

This map shows the geographic impact of Judith Sebolt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Sebolt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Sebolt more than expected).

Fields of papers citing papers by Judith Sebolt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Sebolt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Sebolt. The network helps show where Judith Sebolt may publish in the future.

Co-authorship network of co-authors of Judith Sebolt

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Sebolt. A scholar is included among the top collaborators of Judith Sebolt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Sebolt. Judith Sebolt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Jackson, Robert, Judith Sebolt, Joan L. Shillis, & Wilbur R. Leopold. (1990). The Pyrazoloacridines: Approaches to the Development of a Carcinoma-Selective Cytotoxic Agent. Cancer Investigation. 8(1). 39–47. 34 indexed citations

2.

Sebolt, Judith, et al.. (1989). Activity of the pyrazoloacridines against multidrug-resistant tumor cells. Cancer Chemotherapy and Pharmacology. 24(4). 219–24. 32 indexed citations

3.

Sebolt, Judith, et al.. (1987). Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro.. PubMed. 47(16). 4299–304. 61 indexed citations

4.

Sebolt, Judith, Takashi Aoki, John N. Eble, John L. Glover, & George Weber. (1985). Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma. Biochemical Pharmacology. 34(1). 97–100. 16 indexed citations

5.

Sebolt, Judith & George Weber. (1984). Negative correlation of L-glutamine concentration with proliferation rate in rat hepatomas. Life Sciences. 34(3). 301–306. 23 indexed citations

6.

Denton, J. E., May S. Lui, Takashi Aoki, et al.. (1982). Enzymology of pyrimidine and carbohydrate metabolism in human colon carcinomas.. PubMed. 42(3). 1176–83. 60 indexed citations

7.

Weber, George, Noémi Prajda, May S. Lui, et al.. (1982). Multi-enzyme-targeted chemotherapy by acivicin and actinomycin. Advances in Enzyme Regulation. 20. 75–96. 40 indexed citations

8.

Aoki, Takashi, Judith Sebolt, & George Weber. (1982). In vivo inactivation by acivicin of carbamoylphosphate synthetase II in rat hepatoma. Biochemical Pharmacology. 31(6). 927–932. 30 indexed citations

9.

Denton, J. E., May S. Lui, Takashi Aoki, Judith Sebolt, & George Weber. (1982). Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma. Life Sciences. 30(13). 1073–1080. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact